PDLI - PDL BioPharma, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts1122
Avg. Estimate0.090.080.260.25
Low Estimate0.090.080.190.24
High Estimate0.090.080.330.25
Year Ago EPS0.040.390.710.26
Revenue EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts1122
Avg. Estimate56.9M53.4M195.3M181.55M
Low Estimate56.9M53.4M173.8M180.9M
High Estimate56.9M53.4M216.8M182.2M
Year Ago Sales45.44M143.84M320.06M195.3M
Sales Growth (year/est)25.20%-62.90%-39.00%-7.00%
Earnings History3/30/20176/29/20179/29/201712/30/2017
EPS Est.0.050.090.130.03
EPS Actual0.040.390.140.15
Difference-0.010.30.010.12
Surprise %-20.00%333.30%7.70%400.00%
EPS TrendCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Current Estimate0.090.080.260.25
7 Days Ago0.060.080.250.25
30 Days Ago0.060.080.250.25
60 Days Ago0.20.210.10.25
90 Days Ago0.20.210.370.1
EPS RevisionsCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Up Last 7 Days1N/A1N/A
Up Last 30 Days1N/A1N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesPDLIIndustrySectorS&P 500
Current Qtr.125.00%N/AN/A0.43
Next Qtr.-79.50%N/AN/A0.41
Current Year-63.40%N/AN/A0.21
Next Year-3.80%N/AN/A0.10
Next 5 Years (per annum)14.00%N/AN/A0.12
Past 5 Years (per annum)-24.68%N/AN/AN/A